Bradley Miller

University of Minnesota

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

David Nascene

University of Minnesota

UNITED STATES

View details

Kyriakie Sarafoglou

University of Minnesota

UNITED STATES

View details

Stephan Kemp

Associate Professor & AMC Principal Investigator

Amsterdam UMC, University of Amsterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bradley Miller

Research Interests

Explore related searches

Contact this professor

Articles (20)

Impact of Daily Growth Hormone Adherence on Height Velocity Among Children With Growth Hormone Deficiency (GHD)

Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy

Development of a Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone Therapy in Children with Growth Hormone Deficiency

Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort

Development of specific growth charts for children with Fanconi anemia

Pediatric growth hormone deficiency

Detection rate of IGF-1 variants and their implication to protein binding: study of over 240,000 patients

Insights from an advisory board

Developments in the Management of Growth Hormone Deficiency

Somatrogon injection for the treatment of pediatric growth hormone deficiency with comparison to other LAGH products

Model-based analysis of IGF-I response, dosing, and monitoring for once-weekly somapacitan in children with GH deficiency

Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”

Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH

Approach to the Patient: Case Studies in Pediatric Growth Hormone Deficiency and Their Management

Early-life stress and current stress predict BMI and height growth trajectories in puberty

Literature review and expert opinion on the impact of achondroplasia on medical complications and health-related quality of life and expectations for long-term impact of vosoritide

Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial

What do we do now that the long-acting growth hormone is here?

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency

Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency

Collaborators (3)

David Nascene

Kyriakie Sarafoglou

Stephan Kemp

Make your next move.